Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.

Martino EA, Derudas D, Rossi E, Terlizzi S, Reddiconto G, Stefanoni P, Micozzi J, Mangiacavalli S, Zamagni E, Offidani M, Furlan A, Buda G, Lotti F, Liberatore C, Lazzaro A, Della Pepa R, Bertuglia G, Barbieri E, Conticello C, De Magistris C, De Paoli L, Bongarzoni V, Cafro AM, Mele A, Benvenuti P, Cerchione C, Botta C, Antonioli E, Sgherza N, Aquino S, Mele G, Barilà G, Palmieri S, Annibali O, Bianco R, Febbo MA, Casaluci GM, Rago A, Fontana R, Farina F, Vigna E, Bruzzese A, Mancuso K, Nappi D, Morè S, Rivolti E, Califano C, Amendola A, Roccotelli D, Lombardo A, Citro A, Uccello G, Zambello R, Maggi A, Neri S, Monachesi M, Gozzetti A, Montefusco V, Brunori M, Cotzia E, Pietrantuono G, Quinto AM, Amico V, Di Renzo N, Coscia M, Galli M, De Stefano V, Petrucci MT, Neri A, Di Raimondo F, Morabito F, Musto P, Gentile M

Open source

DOI: 10.3324/haematol.2024.286658
Published: 2025 Apr 1
Container: Haematologica
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2024.286658,
  title = {Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.},
  author = {Martino EA and Derudas D and Rossi E and Terlizzi S and Reddiconto G and Stefanoni P and Micozzi J and Mangiacavalli S and Zamagni E and Offidani M and Furlan A and Buda G and Lotti F and Liberatore C and Lazzaro A and Della Pepa R and Bertuglia G and Barbieri E and Conticello C and De Magistris C and De Paoli L and Bongarzoni V and Cafro AM and Mele A and Benvenuti P and Cerchione C and Botta C and Antonioli E and Sgherza N and Aquino S and Mele G and Barilà G and Palmieri S and Annibali O and Bianco R and Febbo MA and Casaluci GM and Rago A and Fontana R and Farina F and Vigna E and Bruzzese A and Mancuso K and Nappi D and Morè S and Rivolti E and Califano C and Amendola A and Roccotelli D and Lombardo A and Citro A and Uccello G and Zambello R and Maggi A and Neri S and Monachesi M and Gozzetti A and Montefusco V and Brunori M and Cotzia E and Pietrantuono G and Quinto AM and Amico V and Di Renzo N and Coscia M and Galli M and De Stefano V and Petrucci MT and Neri A and Di Raimondo F and Morabito F and Musto P and Gentile M},
  year = {2025},
  journal = {Haematologica},
  doi = {10.3324/haematol.2024.286658},
  url = {https://doi.org/10.3324/haematol.2024.286658}
}

RIS

TY  - JOUR
TI  - Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
AU  - Martino EA
AU  - Derudas D
AU  - Rossi E
AU  - Terlizzi S
AU  - Reddiconto G
AU  - Stefanoni P
AU  - Micozzi J
AU  - Mangiacavalli S
AU  - Zamagni E
AU  - Offidani M
AU  - Furlan A
AU  - Buda G
AU  - Lotti F
AU  - Liberatore C
AU  - Lazzaro A
AU  - Della Pepa R
AU  - Bertuglia G
AU  - Barbieri E
AU  - Conticello C
AU  - De Magistris C
AU  - De Paoli L
AU  - Bongarzoni V
AU  - Cafro AM
AU  - Mele A
AU  - Benvenuti P
AU  - Cerchione C
AU  - Botta C
AU  - Antonioli E
AU  - Sgherza N
AU  - Aquino S
AU  - Mele G
AU  - Barilà G
AU  - Palmieri S
AU  - Annibali O
AU  - Bianco R
AU  - Febbo MA
AU  - Casaluci GM
AU  - Rago A
AU  - Fontana R
AU  - Farina F
AU  - Vigna E
AU  - Bruzzese A
AU  - Mancuso K
AU  - Nappi D
AU  - Morè S
AU  - Rivolti E
AU  - Califano C
AU  - Amendola A
AU  - Roccotelli D
AU  - Lombardo A
AU  - Citro A
AU  - Uccello G
AU  - Zambello R
AU  - Maggi A
AU  - Neri S
AU  - Monachesi M
AU  - Gozzetti A
AU  - Montefusco V
AU  - Brunori M
AU  - Cotzia E
AU  - Pietrantuono G
AU  - Quinto AM
AU  - Amico V
AU  - Di Renzo N
AU  - Coscia M
AU  - Galli M
AU  - De Stefano V
AU  - Petrucci MT
AU  - Neri A
AU  - Di Raimondo F
AU  - Morabito F
AU  - Musto P
AU  - Gentile M
PY  - 2025
JO  - Haematologica
DO  - 10.3324/haematol.2024.286658
UR  - https://doi.org/10.3324/haematol.2024.286658
ER  -

APA

EA, M., D, D., E, R., S, T., G, R., P, S., J, M., S, M., E, Z., M, O., A, F., G, B., F, L., C, L., A, L., R, D. P., G, B., E, B., C, C., C, D. M., L, D. P., V, B., AM, C., A, M., P, B., C, C., C, B., E, A., N, S., S, A., G, M., G, B., S, P., O, A., R, B., MA, F., GM, C., A, R., R, F., F, F., E, V., A, B., K, M., D, N., S, M., E, R., C, C., A, A., D, R., A, L., A, C., G, U., R, Z., A, M., S, N., M, M., A, G., V, M., M, B., E, C., G, P., AM, Q., V, A., N, D. R., M, C., M, G., V, D. S., MT, P., A, N., F, D. R., F, M., P, M., & M, G. (2025). Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.. Haematologica. https://doi.org/10.3324/haematol.2024.286658

Source records

pubmed · retrieved 2026-09-26T15:43:34.188Z